 Effect rifabutin disseminated Mycobacterium avium infections thymectomized T-cell-deficient mice Disseminated Mycobacterium avium infection major cause bacteremia patients acquired immunodeficiency syndrome new animal model disease mice monoclonal antibody cells increased susceptibility animals avium infection comparable beige mice viable alternative latter model Further representative strains acquired immunodeficiency syndrome-associated avium rough isolate course infections thymectomized mice cases infections treatment period regimen mg new antimycobacterial agent rifabutin kg body weight